Aptevo Therapeutics Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Aptevo Therapeutics Inc. (APVO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$460.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- Aptevo Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$457.00K, a 325.12% decline year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$3.00K.
- Aptevo Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$126.00K.
- Aptevo Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$83.00K, a 111.13% decline year-over-year.
- Aptevo Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$483.00K.
- Aptevo Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$217.00K.
- Aptevo Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$153.00K.
- Aptevo Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$355.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$457.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$460.00K 10-Q · filed 2026-08-14 | -$586.00K derived: sum of 3 quarters · filed 2026-08-14 | -$669.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$3.00K 10-Q · filed 2026-05-13 | -$129.00K derived: sum of 2 quarters · filed 2026-05-13 | -$212.00K derived: sum of 3 quarters · filed 2026-05-13 | -$9.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$209.00K derived: sum of 2 quarters · filed 2026-03-26 | -$6.00K derived: sum of 3 quarters · filed 2026-08-14 | -$483.00K 10-K · filed 2026-03-26 | |||
| 2025-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $120.00K derived: sum of 2 quarters · filed 2026-08-14 | -$357.00K 10-Q · filed 2025-11-06 | -$670.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $203.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$274.00K 10-Q · filed 2026-08-14 | -$587.00K derived: sum of 3 quarters · filed 2026-08-14 | $159.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$477.00K 10-Q · filed 2026-05-13 | -$790.00K derived: sum of 2 quarters · filed 2026-05-13 | -$44.00K derived: sum of 3 quarters · filed 2026-05-13 | -$356.00K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$313.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $433.00K derived: sum of 2 quarters · filed 2026-03-26 | $121.00K derived: sum of 3 quarters · filed 2026-03-26 | -$217.00K 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $746.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $434.00K derived: sum of 2 quarters · filed 2025-11-06 | $96.00K 10-Q · filed 2025-11-06 | $242.00K derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$650.00K 10-Q · filed 2025-08-11 | -$504.00K derived: sum of 3 quarters · filed 2025-08-11 | -$162.00K derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | -$338.00K 10-Q · filed 2025-05-15 | -$192.00K derived: sum of 2 quarters · filed 2025-05-15 | $150.00K derived: sum of 3 quarters · filed 2025-05-15 | -$1.33M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $488.00K derived: sum of 2 quarters · filed 2025-02-14 | -$994.00K derived: sum of 3 quarters · filed 2025-02-14 | -$153.00K 10-K · filed 2025-02-14 | |||
| 2023-09-30 | $342.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.14M derived: sum of 2 quarters · filed 2024-11-07 | -$299.00K 10-Q · filed 2024-11-07 | -$24.00K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$641.00K 10-Q · filed 2024-08-08 | -$366.00K derived: sum of 3 quarters · filed 2024-08-08 | $252.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $841.00K 10-Q · filed 2024-05-08 | $1.12M derived: sum of 2 quarters · filed 2024-05-08 | $1.73M derived: sum of 3 quarters · filed 2024-05-08 | $782.00K derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $893.00K derived: sum of 2 quarters · filed 2024-03-05 | -$59.00K derived: sum of 3 quarters · filed 2024-03-05 | -$355.00K 10-K · filed 2024-03-05 | |||
| 2022-09-30 | $618.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$334.00K derived: sum of 2 quarters · filed 2023-11-14 | -$630.00K 10-Q · filed 2023-11-14 | -$1.10M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$952.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.25M 10-Q · filed 2023-08-10 | -$1.72M derived: sum of 3 quarters · filed 2023-08-10 | -$325.00K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$296.00K 10-Q · filed 2023-05-11 | -$771.00K derived: sum of 2 quarters · filed 2023-05-11 | $627.00K derived: sum of 3 quarters · filed 2023-05-11 | -$19.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$475.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $923.00K derived: sum of 2 quarters · filed 2023-03-30 | $277.00K derived: sum of 3 quarters · filed 2023-03-30 | -$436.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $752.00K derived: sum of 2 quarters · filed 2022-11-10 | $39.00K 10-Q · filed 2022-11-10 | $696.00K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | -$646.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.36M 10-Q · filed 2022-08-11 | -$702.00K derived: sum of 3 quarters · filed 2022-08-11 | $252.00K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$713.00K 10-Q · filed 2022-05-12 | -$56.00K derived: sum of 2 quarters · filed 2022-05-12 | $898.00K derived: sum of 3 quarters · filed 2022-05-12 | -$930.00K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $1.61M derived: sum of 2 quarters · filed 2022-03-24 | -$217.00K derived: sum of 3 quarters · filed 2022-03-24 | $1.11M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $954.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$874.00K derived: sum of 2 quarters · filed 2021-11-12 | $455.00K 10-Q · filed 2021-11-12 | $2.93M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$499.00K 10-Q · filed 2021-08-12 | $1.98M derived: sum of 3 quarters · filed 2021-08-12 | -$441.00K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $1.33M 10-Q · filed 2021-05-11 | $3.81M derived: sum of 2 quarters · filed 2021-05-11 | $1.39M derived: sum of 3 quarters · filed 2021-05-11 | -$762.00K derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $58.00K derived: sum of 2 quarters · filed 2021-03-31 | -$2.09M derived: sum of 3 quarters · filed 2021-03-31 | -$2.21M 10-K · filed 2021-03-31 | -$3.61M 10-K · filed 2020-03-25 | ||
| 2019-09-30 | -$2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$4.57M derived: sum of 2 quarters · filed 2020-11-10 | -$4.69M 10-Q · filed 2020-11-10 | -$4.94M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$2.27M 10-Q · filed 2020-08-14 | -$2.52M derived: sum of 3 quarters · filed 2020-08-14 | -$2.31M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$121.00K 10-Q · filed 2020-05-13 | -$376.00K derived: sum of 2 quarters · filed 2020-05-13 | -$166.00K derived: sum of 3 quarters · filed 2020-05-13 | $1.29M derived: sum of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | -$255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$45.00K derived: sum of 2 quarters · filed 2020-03-25 | $1.41M derived: sum of 3 quarters · filed 2020-03-25 | $1.31M 10-K · filed 2020-03-25 | |||
| 2018-09-30 | $210.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.67M derived: sum of 2 quarters · filed 2019-11-07 | $1.57M 10-Q · filed 2019-11-07 | $2.38M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.36M 10-Q · filed 2019-08-09 | $2.17M derived: sum of 3 quarters · filed 2019-08-09 | $2.69M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | -$97.00K 10-Q · filed 2019-05-09 | $716.00K derived: sum of 2 quarters · filed 2019-05-09 | $1.23M derived: sum of 3 quarters · filed 2019-05-09 | $725.00K derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $813.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.33M derived: sum of 2 quarters · filed 2019-03-18 | $822.00K derived: sum of 3 quarters · filed 2019-03-18 | $1.63M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $514.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $9.00K derived: sum of 2 quarters · filed 2018-11-14 | $815.00K 10-Q · filed 2018-11-14 | $2.56M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | -$505.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $301.00K 10-Q · filed 2018-08-09 | $302.00K 10-Q · filed 2017-08-10 | $2.05M derived: sum of 3 quarters · filed 2018-08-09 | $1.96M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | $806.00K 10-Q · filed 2018-05-10 | $550.00K 10-Q · filed 2017-05-12 | $2.55M derived: sum of 2 quarters · filed 2018-05-10 | $2.46M derived: sum of 3 quarters · filed 2018-05-10 | $936.00K derived: sum of 4 quarters · filed 2018-05-10 | ||
| 2016-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $1.66M derived: sum of 2 quarters · filed 2018-03-13 | $130.00K derived: sum of 3 quarters · filed 2018-03-13 | $3.22M 10-K · filed 2018-03-13 | |||
| 2016-09-30 | -$90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$1.62M derived: sum of 2 quarters · filed 2017-11-13 | $1.48M 10-Q · filed 2017-11-13 | $234.00K derived: sum of 4 quarters · filed 2017-11-13 | |||
| 2016-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $1.56M 10-Q · filed 2017-08-10 | $324.00K derived: sum of 3 quarters · filed 2017-08-10 | -$2.02M derived: sum of 4 quarters · filed 2017-08-10 | |||
| 2016-03-31 | $3.09M 10-Q · filed 2017-05-12 | $1.85M derived: sum of 2 quarters · filed 2017-05-12 | -$491.00K derived: sum of 3 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$3.58M derived: sum of 2 quarters · filed 2017-03-31 | -$2.86M 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | -$2.34M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | -$1.62M 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $724.00K 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |